SCHEMBL26075408

SCHEMBL26075408

Cc1ccc2nc(-c3ccc(-c4ccc(Oc5ccccc5)cc4)c(F)c3)cc(C=O)c2c1

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ DHODH Q02127 7/20 0.45
▸ MAPT P10636 7/20 0.44
▸ ALDH1A1 P00352 6/20 0.42
▸ LMNA P02545 4/20 0.42
▸ KDM4E B2RXH2 4/20 0.42
▸ NPSR1 Q6W5P4 3/20 0.42
▸ MEN1 O00255 1/20 0.42
▸ RECQL P46063 1/20 0.42
▸ KMT2A Q03164 1/20 0.42
▸ HSP90AA1 P07900 3/20 0.41
▸ HPGD P15428 3/20 0.41
▸ THRB P10828 3/20 0.41
▸ GAA P10253 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.40
▸ ESR1 P03372 1/20 0.39
▸ ESR2 Q92731 1/20 0.39
▸ MAPK1 P28482 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ L3MBTL1 Q9Y468 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26075337 0.89 MAPT (0.49) DHODHMAPTALDH1A1LMNAKDM4E
SCHEMBL26075369 0.87 KDM4E (0.40) DHODHMAPTALDH1A1LMNAKDM4E
SCHEMBL26075381 0.87 MAPT (0.38) DHODHMAPTALDH1A1LMNAKDM4E
SCHEMBL26075922 0.84 DHODH (0.66) DHODHMAPTALDH1A1LMNAKDM4E
SCHEMBL26075378 0.84 XDH (0.39) DHODHMAPTALDH1A1LMNAKDM4E
SCHEMBL26075426 0.83 ALDH1A1 (0.45) DHODHMAPTALDH1A1LMNAKDM4E
SCHEMBL26075421 0.83 ALDH1A1 (0.40) DHODHMAPTALDH1A1LMNAKDM4E
SCHEMBL26075413 0.82 KDM4E (0.42) DHODHMAPTALDH1A1LMNAKDM4E
SCHEMBL26075401 0.82 DHODH (0.44) DHODHMAPTALDH1A1LMNAKDM4E
SCHEMBL26075308 0.81 DHODH (0.55) DHODHALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT OHIO STATE INNOVATION FOUNDATION (US) 2023-09-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230303710-A1 METHODS AND COMPOSITIONS FOR INHIBITION OF DIHYDROOROTATE DEHYDROGENASE IN COMBINATION WITH AN ANTI-CD38 THERAPEUTIC AGENT DHODH, CD38, DPYD DHODH 1/4885MAPT 2689/4885ALDH1A1 88/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback